|
|
Correlation study of expression of ADAM8, IRF1 in peripheral blood and pulmonary function in children with bronchial asthma |
WANG Kaimei1 HU Xiangying1 ZHENG Guangqiang1 QIU Wenhai2 LIN Zhixiong1 |
1.Department of Pediatrics, Haikou Women & Children Hospital, Hainan Province, Haikou 570102, China;
2.Department of Pediatrics, West China Second Hospital, Sichuan University, Sichuan Province, Chengdu 610015, China |
|
|
Abstract Objective To study the correlation of the expression of deintegrin metalloproteinase 8 (ADAM8), interferon regulatory factor 1 (IRF1) in peripheral blood and pulmonary function in children with bronchial asthma (BA). Methods Eighty-four children with BA who were treated in Haikou Women & Children Hospital ("our hospital" for short) from January to August 2018 were selected as observation group, and they were divided into mild group (30 cases), moderate group (44 cases) and severe group (10 cases) according to the severity of the disease. Eighty healthy children who underwent physical examination in our hospital at the same time were selected as control group. The pulmonary function indices, the expression levels of ADAM8, IRF1 mRNA and protein in peripheral blood of each group were detected and compared. The correlation between the expression of ADAM8, IRF1 protein in peripheral blood and pulmonary function indices was analyzed. Results The expression levels of ADAM8, IRF1 mRNA and protein in peripheral blood of observation group and mild, moderate, severe group were significantly higher than those of the control group, the differences were highly statistically significant (P < 0.01); the expression levels of ADAM8, IRF1 mRNA and protein in peripheral blood of the severe group and moderate group were significantly higher than the mild group, and those of the severe group were significantly higher than the moderate group, the differences were statistically significant (P < 0.05). The forced expiratory volume in 1 second (FEV1), FEV1/forced vital capacity (FEV1/FVC), peak expiratory flow (PEF) in the observation group and mild, moderate, severe group were significantly lower than the control group, the differences were statistically significant (P < 0.05). The levels of FEV1, FEV1/FVC and PEF in the severe group and moderate group were significantly lower than the mild group, while the severe group was significantly lower than the moderate group, the differences were statistically significant (P < 0.05). Pearson correlation analysis showed that, the expression of ADAM8, IRF1 protein was negatively correlated with FEV1, FEV1/FVC and PEF (rADAM8=-0.780, -0.773, -0.682, P < 0.01; rIRF1=-0.684, -0.710, -0.768, P < 0.01). Conclusion The expression of levels ADAM8 and IRF1 in peripheral blood of children with BA are significantly increased, and it is closely related to pulmonary function. It can be considered as the monitoring target of children with BA, in order to assist the diagnosis and treatment process.
|
|
|
|
|
[1] 刘敏,易国萍,张良,等.高强度间歇运动锻炼联合药物治疗对哮喘患儿气道功能、炎性因子分泌的影响[J].海南医学院学报,2018,24(3):331-334.
[2] 郭楠,张梦.综合排痰辅助治疗小儿哮喘样支气管炎效果观察及对患儿气道高反应性的预防分析[J].罕少疾病杂志,2018,25(1):30-32.
[3] 李小卉,陈俊松.硫酸镁联合硫酸沙丁胺醇雾化吸入对支气管哮喘急性发作期患儿外周血中性粒细胞弹性蛋白酶水平的影响研究[J].国际医药卫生导报,2018,24(4):470-472.
[4] Paulissen G,Rocks N,Gueders MM,et al. ADAM-8,a met-alloproteinase,drives acute allergen-induced airway inflam-mation [J]. Eur J Immunol,2011,41(2):380-391.
[5] 中华医学会儿科学分会呼吸学组,《中华儿科杂志》编辑委员会.儿童支气管哮喘诊断与防治指南(2016年版)[J].中华儿科杂志,2016,54(3):167-181.
[6] Knolle MD,Nakajima T,Hergrueter A,et al. Adam8 limits the development of allergic airway inflammation in mice [J]. J Immunol,2013,190(12):6434-6449.
[7] 王建荣,吕既寿,多力坤·木扎帕尔,等.ADAM33基因F+1多态性、IgE、维生素D与乌鲁木齐地区维吾尔族、汉族哮喘儿童的相关性研究[J].新疆医科大学学报,2017, 40(1):62-65.
[8] 肖秋林,秦晓敏.沙美特罗替卡松联合孟鲁司特对咳嗽变异性哮喘患儿肺功能及血清炎性因子的影响[J].中国基层医药,2018,25(2):182-185.
[9] Chen J,Jiang X,Duan Y,et al. ADAM8 in asthma. Friend or foe to airway inflammation [J]. Am J Respir Cell Mol Biol,2013,49(6):875-884.
[10] 曹欣,刘章华,任加红.吸入性沙美特罗替卡松联合孟鲁司特钠治疗儿童支气管哮喘的临床分析[J].医学综述,2018,24(18):3728-3732.
[11] 罗亚辉,廖志雄.长期吸入不同糖皮质激素类药物对支气管哮喘患儿生长发育的影响[J].河北医学,2017,23(4):628-632.
[12] 陈光熹,杨永红.支气管哮喘患者小气道功能评估及治疗的研究进展[J].医学综述,2018,24(22):4507-4511.
[13] 车向郁.支气管哮喘儿童血清25-(OH)D3、IgE、IL-17、TGF-β1水平变化及意义[J].成都医学院学报,2017,12(3):306-308.
[14] 梁雯慧,庄帝钱,刘雅玲,等.支气管哮喘患儿外周血中ADAM8,IRF1的表达水平及其临床意义[J].临床与病理杂志,2017,37(12):2583-2588.
[15] 李茉莉,潘频华,胡成平,等.干扰素调节因子1在呼吸道合胞病毒感染后气道神经源性炎症的调控作用[J].中国现代医学杂志,2013,23(18):21-24.
[16] 陈福将,蔡振荡,李锐,等.毛细支气管炎患儿外周血 ADAM8、CD23 水平及临床意义[J].浙江中西医结合杂志,2014,24(11):996-997.
[17] 叶金汉,陈广.喘可治联合布地奈德治疗咳嗽变异性哮喘的效果及对炎症介质、免疫失衡的影响[J].现代医院,2018,18(3):411-413.
[18] 吕既寿,江丽汗·阿黑哈提,王建荣,等.ADAM33基因V4位点多态性和维生素D水平与乌鲁木齐地区支气管哮喘儿童相关性研究[J].中国儿童保健杂志,2017, 25(3):248-250.
[19] 张秋玲,韩超,徐俊,等.翘芩清肺剂对哮喘大鼠气道平滑肌细胞外信号调节激酶通路的影响[J].世界中医药,2018,13(7):167-171.
[20] Holgate ST. Innate and adaptive immune responses in asthma [J]. Nat Med,2012,18(5):673-683.
[21] 姚丽丹,崔世红,齐曼古力·吾守尔,等.去整合素金属蛋白酶33基因多态性与新疆维吾尔族人群支气管哮喘及其严重程度的关系[J].中华医学杂志,2014,94(24):1866-1869.
[22] Dou L,Liang HF,Geller DA,et al. regulation role of interferon regulatory factor-1 gene and clinical relevance [J]. Hum Immunol,2014,75(11):1110-1114.
[23] 张珺.干扰素调节因子4与T细胞分化及免疫性疾病的研究进展[J].医学综述,2016,22(1):9-12.
[24] 李越峰,张睿,王佳,等.宣肺益气散对支气管哮喘缓解期肺脾气虚证患者疗效及免疫功能影响[J].临床军医杂志,2018,46(2):136-138. |
|
|
|